CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk Healthcare Alivus Life Sciences Ltd

Alivus Life Sciences Ltd

BSE 543322 ALIVUS INE03Q201024
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

26 filings · 7 material · busiest 2026-07-30

What it files

Filings

26 in the window

  1. 25 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meetings

    Company Update / Analyst / Investor Meet View filing →

  2. 18 August 2026

    Acquisition

    Acquisition

    Enclosed please find herewith intimation pursuant to Regulation 30 of SEBI (LODR), 2015 with respect to acquisition.

    Company Update / Acquisition View filing →

  3. 18 August 2026

    Press Release

    Press Release / Media Release

    Enclosed please find herewith Press Release with respect to Acquisition.

    Company Update / Press Release / Media Release View filing →

  4. 13 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed herewith Newspaper Advertisement of Notice of 15th Annual General Meeting and E-Voting information.

    Company Update / Newspaper Publication View filing →

  5. 13 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting

    Company Update / Analyst / Investor Meet View filing →

  6. 11 August 2026

    AGM / EGM

    Notice Of 15Th Annual General Meeting Of The Company For FY 2025-26 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find attached herewith Notice convening the 15th Annual General Meeting.

    AGM/EGM / AGM View filing →

  7. 11 August 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Please find enclosed herewith Integrated Annual Report FY 2025-26 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Others / Reg. 34 (1) Annual Report View filing →

  8. 11 August 2026

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Please find enclosed herewith the Business Responsibility & Sustainability Report for FY 2025-26

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  9. 7 August 2026

    Concall Transcript

    Earnings Call Transcript

    Please find attached herewith transcript of Earnings call held on 31 July, 2026.

    Company Update / Earnings Call Transcript View filing →

  10. 7 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please find attached herewith details of Analyst/Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  11. 7 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Enclosed please find herewith details of investor meet.

    Company Update / Analyst / Investor Meet View filing →

  12. 6 August 2026

    AGM / EGM

    Intimation Of 15Th Annual General Meeting And Record Date.

    Intimation of 15th Annual General Meeting and Record date.

    AGM/EGM / AGM View filing →

  13. 6 August 2026

    Record Date

    Intimation Of Record Date For Dividend

    Intimation of Record date for Dividend.

    Corp. Action / Record Date View filing →

  14. 6 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement for 15th Annual General Meeting (AGM)

    Company Update / Newspaper Publication View filing →

  15. 31 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    We hereby confirm that we have uploaded audio recording of the Q1 FY2027 Earnings Call held on July 31, 2026 on the website of the Company.

    Company Update / Analyst / Investor Meet View filing →

  16. 30 July 2026

    Board Outcome

    Board Meeting Outcome for Unaudited Financial Results For The First Quarter Ended June 30, 2026

    Enclosed please find herewith unaudited financial results for the first quarter ended June 30, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  17. 30 July 2026

    Results

    Unaudited Financial Results For The First Quarter Ended June 30, 2026.

    Enclosed please find herewith unaudited financial results for the first quarter ended June 30, 2026.

    Result / Financial Results View filing →

  18. 30 July 2026

    Press Release

    Press Release / Media Release

    Enclosed please find herewith Press Release of the Company for the first quarter ended June 30, 2026.

    Company Update / Press Release / Media Release View filing →

  19. 30 July 2026

    Investor Presentation

    Investor Presentation

    Enclosed please find herewith Investors Presentation for Q1 FY 2026-27.

    Company Update / Investor Presentation View filing →

  20. 30 July 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    Enclosed please find herewith intimation with respect to allotment of equity shares under 'Employee Stock Options Scheme, 2021'

    Company Update / Allotment of ESOP / ESPS View filing →

  21. 23 July 2026

    Board Meeting

    Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.

    Alivus Life Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the Unaudited Financial ....

    Board Meeting / Board Meeting View filing →

  22. 23 July 2026

    Trading Window

    Closure of Trading Window

    Intimation of closure of Trading Window from 1st July, 2026 to 1st August, 2026 (both days inclusive), for the purpose of approval of unaudited financial results for the quarter ended 30th June, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

  23. 23 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Enclosed please find herewith the details of Earnings Call slated for Friday, July 31, 2026 from 8:30 a.m. to 9:30 a.m. (IST), for your information and record.

    Company Update / Analyst / Investor Meet View filing →

  24. 23 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Institutional Investor Meeting - Plant Visit

    Company Update / Analyst / Investor Meet View filing →

  25. 10 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Analyst / Institutional Investor Meeting.

    Company Update / Analyst / Investor Meet View filing →

  26. 4 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting

    Company Update / Analyst / Investor Meet View filing →